Sinil Pharmaceutical financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

신일제약KRX:012790 · KOSDAQ · Healthcare

₩6,500+0.93%

2026-10-02 close

Sinil Pharmaceutical's published financial data is dated 2026-10-04. 2024 revenue was KRW 89.44B. 2024 operating profit was KRW 15.25B.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy